• shareshare
  • link
  • cite
  • add
auto_awesome_motion View all 2 versions
Other research product . Other ORP type . 2020

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia

Sánchez-Pernaute, Olga; Romero-Bueno, Fredeswinda; Selva-O´Callaghan, Albert;
Open Access
Published: 16 Apr 2020
Publisher: Elsevier
Country: Spain

Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active


immunosuppressive therapies, COVID-19, Medicina

Related Organizations
Related to Research communities